A method of using pyroloquinoline quinone as a coenzyme of 2-aminoadipate 6-semialdehyde dehydrogenase.
The present invention provides an aerosol formulation of a 3-hydroxy-3-methyl-glutaryl coenzyme A (HMG-CoA) reductase inhibitor.
